This flaw might yield false negative results in samples harbouring pathogenic indels: in our previous study, tumour sequencing of one ovarian cancer patient failed to identify a germline pathogenic BRCA2 deletion at a homopolymeric region. This evidence concerns the gene BRCA2 and neoplasm.